SANTA MONICA, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) today announced that the management team will participate in two upcoming investor conferences this month:
- 10th Annual Citi Biotech Conference
Date: Thursday, September 10, 2015
Time: 11:00am Eastern Time
Location: New York, NY
- Morgan Stanley Global Healthcare Conference
Date: Thursday, September 17, 2015
Time: 1:30pm Eastern Time
Location: New York, NY
The Company’s corporate overview to be presented at the Morgan Stanley Global Healthcare Conference will be available through the Calendar of Events section of the Company’s website at ir.kitepharma.com.
About Kite Pharma
Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system’s ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com.
CONTACT: Kite Pharma Cynthia M. Butitta Chief Financial Officer and Chief Operating Officer 310-824-9999 For Media: Justin Jackson For Investor Inquiries: Lisa Burns Burns McClellan 212-213-0006 jjackson@burnsmc.com lburns@burnsmc.com
Help employers find you! Check out all the jobs and post your resume.
